Ioannis Tomazos

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Cross Sectional

Combination Therapy

Catheter Ablation

Top Venues

Annals of hematology

Journal of patient-reported outcomes

Orphanet journal of rare diseases

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Enrico Bertini, Emily Gregg, Chris Bartlett, Vij Senthilnathan, Mick Arber, Deborah Watkins, Sara Graziadio, Ioannis Tomazos
The burden of mitochondrial disease with associated seizures: systematic literature reviews of health-related quality of life, utilities, costs and healthcare resource use data. Orphanet journal of rare diseases 18 (1) (2023)
Hubert Schrezenmeier, Austin G Kulasekararaj, Lindsay Mitchell, Regis Peffault de Latour, Timothy Devos, Shinichiro Okamoto, Richard Wells, Evan Popoff, Antoinette Cheung, Alice Wang, Ioannis Tomazos, Yogesh Patel, Jong Wook Lee
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria. Annals of hematology (2023)
Jamile Shammo, Ajeet Gajra, Yogesh Patel, Ioannis Tomazos, Jonathan K Kish, Anita Hill, J Rafael Sierra, David Araten
Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study. Journal of blood medicine 13 (2022)
Adrian R Levy, Peter Chen, Karissa M Johnston, Yan Wang, Evan Popoff, Ioannis Tomazos
Quantifying the economic effects of ravulizumab versus eculizumab treatment in patients with atypical hemolytic uremic syndrome. Journal of medical economics 25 (1) (2022)
Thomas O'Connell, Marric Buessing, Scott Johnson, Lufei Tu, Simu K Thomas, Ioannis Tomazos
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria. PharmacoEconomics 38 (9) (2021)
Helen A Doll, Ufuk Coşkun, Christopher A Hartford, Ioannis Tomazos
Concept confirmation of the Treatment Administration Satisfaction Questionnaire (TASQ) in rare paroxysmal nocturnal hemoglobinuria. Journal of patient-reported outcomes 5 (1) (2021)